Other
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
Biogen Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 increased by 266.1% to $20.5M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 113.5%, from $9.6M to $20.5M.
Analysis
StatementIncome Statement
SectionOther
First reportedQ3 2023
Last reportedQ1 2026Apr 29, 2026
Metric ID:
other_business_combination_contingent_consideration_arra_61a2d2Historical Data
8 periods
| Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $0 | $0 | $0 | $23.8M | $9.6M | $13.2M | $5.6M | $20.5M |
| QoQ Change | — | — | — | — | -59.7% | +37.5% | -57.6% | +266.1% |
| YoY Change | — | — | — | — | — | — | -76.5% | +113.5% |
Range$0 – $23.8M
Avg YoY Growth+18.5%
Median YoY Growth+18.5%
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 at Other Companies
Frequently Asked Questions
- What is Biogen's business combination contingent consideration arrangements change in amount of contingent consideration liability1?
- Biogen (BIIB) reported business combination contingent consideration arrangements change in amount of contingent consideration liability1 of $20.5M in Q1 2026.
- How has Biogen's business combination contingent consideration arrangements change in amount of contingent consideration liability1 changed year-over-year?
- Biogen's business combination contingent consideration arrangements change in amount of contingent consideration liability1 increased by 113.5% year-over-year, from $9.6M to $20.5M.